Illumen Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Illumen Therapeutics General Information

Description

Developer of cancer treatment drugs designed to address the root cause of many cancers by restoring the body's natural defense mechanisms. The company focuses on inhibiting a specific enzyme, PARN (Poly(A)-specific ribonuclease), to increase the function of the tumor suppressor protein, enabling researchers to develop new treatment options for aggressive cancer types.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 4845 Pearl East Circle
  • Suite 118 PMB 58457
  • Boulder, CO 80301
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4845 Pearl East Circle
  • Suite 118 PMB 58457
  • Boulder, CO 80301
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Illumen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 18-Mar-2025 Completed Startup
2. Accelerator/Incubator 01-Jan-2024 Completed Startup
1. Spin-Off Completed Startup
To view Illumen Therapeutics’s complete valuation and funding history, request access »

Illumen Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Venture Partners at CU Boulder Accelerator/Incubator
National Science Foundation Innovation Corps Program Accelerator/Incubator
University of Colorado, Boulder Corporation Minority
To view Illumen Therapeutics’s complete investors history, request access »

Illumen Therapeutics FAQs

  • When was Illumen Therapeutics founded?

    Illumen Therapeutics was founded in 2024.

  • Where is Illumen Therapeutics headquartered?

    Illumen Therapeutics is headquartered in Boulder, CO.

  • What industry is Illumen Therapeutics in?

    Illumen Therapeutics’s primary industry is Drug Discovery.

  • Is Illumen Therapeutics a private or public company?

    Illumen Therapeutics is a Private company.

  • What is Illumen Therapeutics’s current revenue?

    The current revenue for Illumen Therapeutics is .

  • Who are Illumen Therapeutics’s investors?

    Venture Partners at CU Boulder, National Science Foundation Innovation Corps Program, and University of Colorado, Boulder have invested in Illumen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process